Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Venous Thrombosis

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 77 articles:
HTML format

Single Articles

    January 2020
  1. OWODUNNI OP, Haut ER, Shaffer DL, Hobson DB, et al
    Using electronic health record system triggers to target delivery of a patient-centered intervention to improve venous thromboembolism prevention for hospitalized patients: Is there a differential effect by race?
    PLoS One. 2020;15:e0227339.
    PubMed     Abstract available

  2. PENG YH, Lin YS, Chen CH, Tsai KY, et al
    Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
    PLoS One. 2020;15:e0226997.
    PubMed     Abstract available

  3. BUI MH, Le QC, Duong DH, Nguyen TS, et al
    Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam.
    PLoS One. 2020;15:e0231411.
    PubMed     Abstract available

  4. SIDDAPPA MALLESHAPPA SK, Valecha GK, Mehta T, Patel S, et al
    Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope.
    PLoS One. 2020;15:e0230859.
    PubMed     Abstract available

  5. BOON GJAM, Rein NV, Bogaard HJ, Ende-Verhaar YM, et al
    Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.
    PLoS One. 2020;15:e0232354.
    PubMed     Abstract available

    January 2019
  6. PATEL DC, Gaba RC, Liu L, Lokken RP, et al
    Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism.
    PLoS One. 2019;14:e0211701.
    PubMed     Abstract available

  7. NAITO A, Hiwasa T, Tanabe N, Sanada TJ, et al
    Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2019;14:e0211377.
    PubMed     Abstract available

  8. SHIN JM, Hong SJ, Choi KH, Shin SI, et al
    Low relative muscle volume: Correlation with prevalence of venous thromboembolism following total knee arthroplasty.
    PLoS One. 2019;14:e0210800.
    PubMed     Abstract available

  9. KIM YG, Shim J, Boo KY, Kim DY, et al
    Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation.
    PLoS One. 2019;14:e0214743.
    PubMed     Abstract available

  10. MAI V, Bertoletti L, Cucherat M, Jardel S, et al
    Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
    PLoS One. 2019;14:e0214134.
    PubMed     Abstract available

  11. GUPTA AK, Chopra BS, Vaid B, Sagar A, et al
    Protective effects of gelsolin in acute pulmonary thromboembolism and thrombosis in the carotid artery of mice.
    PLoS One. 2019;14:e0215717.
    PubMed     Abstract available

  12. COTTIN V, Avot D, Levy-Bachelot L, Baxter CA, et al
    Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database.
    PLoS One. 2019;14:e0214649.
    PubMed     Abstract available

  13. DOUILLET D, Nemeth B, Penaloza A, Le Gal G, et al
    Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization.
    PLoS One. 2019;14:e0217748.
    PubMed     Abstract available

  14. LEGNANI C, Martinelli I, Palareti G, Ciavarella A, et al
    D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.
    PLoS One. 2019;14:e0219751.
    PubMed     Abstract available

  15. CHANG H, Kim MS, Lee SY, Shin SH, et al
    Does anticoagulation needed for distally located incidental pulmonary thromboembolism in patients with active cancer?
    PLoS One. 2019;14:e0222149.
    PubMed     Abstract available

  16. HUA X, Han SH, Wei SZ, Wu Y, et al
    Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis.
    PLoS One. 2019;14:e0223230.
    PubMed     Abstract available

  17. BELLIN A, Berto P, Themistoclakis S, Chandak A, et al
    New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.
    PLoS One. 2019;14:e0222762.
    PubMed     Abstract available

  18. SUDARSKI S, Haubenreisser H, Henzler T, Reischauer C, et al
    Incidence of transient interruption of contrast (TIC) - A retrospective single-centre analysis in CT pulmonary angiography exams acquired during inspiratory breath-hold with the breathing command: "Please inspire gently!"
    PLoS One. 2019;14:e0210473.
    PubMed     Abstract available

    January 2018

  19. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2018;13:e0191454.
    PubMed     Abstract available

  20. HONG J, Lee JH, Yhim HY, Choi WI, et al
    Incidence of venous thromboembolism in Korea from 2009 to 2013.
    PLoS One. 2018;13:e0191897.
    PubMed     Abstract available

  21. CHEN Y, Deng X, Shan X, Xing Y, et al
    Study of helical flow inducers with different thread pitches and diameters in vena cava.
    PLoS One. 2018;13:e0190609.
    PubMed     Abstract available

  22. JIMENEZ-ALCAZAR M, Limacher A, Panda R, Mean M, et al
    Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.
    PLoS One. 2018;13:e0191150.
    PubMed     Abstract available

  23. EPSTEIN D, Berger G, Barda N, Marcusohn E, et al
    The incidence of acute pulmonary embolism following syncope in anticoagulant-naive patients: A retrospective cohort study.
    PLoS One. 2018;13:e0193725.
    PubMed     Abstract available

  24. JARA-PALOMARES L, Otero R, Jimenez D, Praena-Fernandez JM, et al
    Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.
    PLoS One. 2018;13:e0194673.
    PubMed     Abstract available

  25. HANSEN PW, Sehested TSG, Fosbol EL, Torp-Pedersen C, et al
    Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011.
    PLoS One. 2018;13:e0194295.
    PubMed     Abstract available

  26. EICHINGER S, Eischer L, Sinkovec H, Wittgruber G, et al
    Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury.
    PLoS One. 2018;13:e0193735.
    PubMed     Abstract available

  27. Retraction: Percutaneous Aspiration Thrombectomy for Arterial Thromboembolism during Infrainguinal Endovascular Recanalization.
    PLoS One. 2018;13:e0196768.

  28. HERAUDEAU A, Delluc A, Le Henaff M, Lacut K, et al
    Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
    PLoS One. 2018;13:e0194973.
    PubMed     Abstract available

  29. KHIRFAN G, Tejwani V, Wang X, Li M, et al
    Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0197700.
    PubMed     Abstract available

  30. UHRIG M, Simons D, Schlemmer HP
    Incidental pulmonary emboli in stage IV melanoma patients: Prevalence in CT staging examinations and improved detection with vessel reconstructions based on dual energy CT.
    PLoS One. 2018;13:e0199458.
    PubMed     Abstract available

  31. GROSSE A, Grosse C, Lang I
    Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0201468.
    PubMed     Abstract available

  32. FIGUEROA R, Alfonso A, Lopez-Picazo J, Gil-Bazo I, et al
    Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
    PLoS One. 2018;13:e0200220.
    PubMed     Abstract available

  33. ROLIM JV, Ota-Arakaki JS, Ferreira EVM, Figliolino GAM, et al
    Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0204072.
    PubMed     Abstract available

  34. KRIECHBAUM SD, Wiedenroth CB, Keller T, Wolter JS, et al
    Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0204683.
    PubMed     Abstract available

  35. GEZELIUS E, Flou Kristensen A, Bendahl PO, Hisada Y, et al
    Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
    PLoS One. 2018;13:e0207387.
    PubMed     Abstract available

  36. JOHNSTON A, Hsieh SC, Carrier M, Kelly SE, et al
    A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.
    PLoS One. 2018;13:e0207410.
    PubMed     Abstract available

  37. AUDIA S, Bach B, Samson M, Lakomy D, et al
    Venous thromboembolic events during warm autoimmune hemolytic anemia.
    PLoS One. 2018;13:e0207218.
    PubMed     Abstract available

  38. TROMEUR C, Jais X, Mercier O, Couturaud F, et al
    Factors predicting outcome after pulmonary endarterectomy.
    PLoS One. 2018;13:e0198198.
    PubMed     Abstract available

    January 2017
  39. KONIGSBRUGGE O, Posch F, Antlanger M, Kovarik J, et al
    Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    PLoS One. 2017;12:e0169400.
    PubMed     Abstract available

  40. PERNOD G, Caterino J, Maignan M, Tissier C, et al
    D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?
    PLoS One. 2017;12:e0169268.
    PubMed     Abstract available

  41. NAM KW, Kim CK, Kim TJ, An SJ, et al
    Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
    PLoS One. 2017;12:e0172793.
    PubMed     Abstract available

  42. BEZAN A, Posch F, Ploner F, Bauernhofer T, et al
    Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
    PLoS One. 2017;12:e0176283.
    PubMed     Abstract available

  43. YHIM HY, Lee J, Lee JY, Lee JO, et al
    Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    PLoS One. 2017;12:e0178214.
    PubMed     Abstract available

  44. ROBIN P, Le Roux PY, Lacut K, Planquette B, et al
    Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
    PLoS One. 2017;12:e0178849.
    PubMed     Abstract available

  45. MEAN M, Tritschler T, Limacher A, Breault S, et al
    Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.
    PLoS One. 2017;12:e0179224.
    PubMed     Abstract available

  46. LEE FY, Chen WK, Chiu CH, Lin CL, et al
    Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study.
    PLoS One. 2017;12:e0178587.
    PubMed     Abstract available

  47. LAU JK, Chow V, Brown A, Kritharides L, et al
    Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management.
    PLoS One. 2017;12:e0179755.
    PubMed     Abstract available

  48. TORTOSA C, Cabrera-Marante O, Serrano M, Martinez-Flores JA, et al
    Incidence of thromboembolic events in asymptomatic carriers of IgA anti ss2 glycoprotein-I antibodies.
    PLoS One. 2017;12:e0178889.
    PubMed     Abstract available

  49. HASEGAWA S, Matsui T, Hane Y, Abe J, et al
    Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
    PLoS One. 2017;12:e0182045.
    PubMed     Abstract available

  50. ZHANG Q, Wang D, Zhang M, Zhao Y, et al
    Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis.
    PLoS One. 2017;12:e0170334.
    PubMed     Abstract available

  51. LAU BD, Shaffer DL, Hobson DB, Yenokyan G, et al
    Effectiveness of two distinct web-based education tools for bedside nurses on medication administration practice for venous thromboembolism prevention: A randomized clinical trial.
    PLoS One. 2017;12:e0181664.
    PubMed     Abstract available

  52. NAGATA N, Sakurai T, Moriyasu S, Shimbo T, et al
    Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    PLoS One. 2017;12:e0183423.
    PubMed     Abstract available

  53. MOUNTAIN D, Keijzers G, Chu K, Joseph A, et al
    Correction: RESPECT-ED: Rates of Pulmonary Emboli (PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or
    PLoS One. 2017;12:e0184219.
    PubMed     Abstract available

  54. HERNANDEZ-LOPEZ R, Chavez-Gonzalez A, Torres-Barrera P, Moreno-Lorenzana D, et al
    Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction.
    PLoS One. 2017;12:e0183827.
    PubMed     Abstract available

  55. MUELLER C, Limacher A, Mean M, Rodondi N, et al
    Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.
    PLoS One. 2017;12:e0184868.
    PubMed     Abstract available

  56. TASHIMA Y, Banno F, Kita T, Matsuda Y, et al
    Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions.
    PLoS One. 2017;12:e0180981.
    PubMed     Abstract available

  57. LIPSKA-ZIETKIEWICZ BS, Gellermann J, Boyer O, Gribouval O, et al
    Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia.
    PLoS One. 2017;12:e0180926.
    PubMed     Abstract available

  58. WANG L, Baser O, Wells P, Peacock WF, et al
    Benefit of early discharge among patients with low-risk pulmonary embolism.
    PLoS One. 2017;12:e0185022.
    PubMed     Abstract available

  59. LEE SY, Kim EK, Kim MS, Shin SH, et al
    The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.
    PLoS One. 2017;12:e0185785.
    PubMed     Abstract available

  60. SUNTHARALINGAM S, Mikat C, Stenzel E, Erfanian Y, et al
    Submillisievert standard-pitch CT pulmonary angiography with ultra-low dose contrast media administration: A comparison to standard CT imaging.
    PLoS One. 2017;12:e0186694.
    PubMed     Abstract available

  61. NAM JH, Kim DH, Yoo JH, Hwang JH, et al
    Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?-Retrospective case-control study.
    PLoS One. 2017;12:e0187337.
    PubMed     Abstract available

  62. CUNHA MLR, Meijers JCM, Rosendaal FR, Vlieg AVH, et al
    Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.
    PLoS One. 2017;12:e0187699.
    PubMed     Abstract available

  63. BARRIOS D, Morillo R, Guerassimova I, Barbero E, et al
    Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism.
    PLoS One. 2017;12:e0187648.
    PubMed     Abstract available

  64. ENDE-VERHAAR YM, Kroft LJM, Mos ICM, Huisman MV, et al
    Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism.
    PLoS One. 2017;12:e0188862.
    PubMed     Abstract available

  65. LIU YY, Chiang CH, Hung SC, Chian CF, et al
    Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury.
    PLoS One. 2017;12:e0187637.
    PubMed     Abstract available

  66. KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
    Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2017;12:e0189410.
    PubMed     Abstract available

    January 2016
  67. SMABREKKE B, Rinde LB, Hindberg K, Hald EM, et al
    Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromso Study.
    PLoS One. 2016;11:e0163242.
    PubMed     Abstract available

  68. COHEN AT, Hamilton M, Bird A, Mitchell SA, et al
    Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    PLoS One. 2016;11:e0163386.
    PubMed     Abstract available

  69. YEH JJ, Wang YC, Kao CH
    Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism.
    PLoS One. 2016;11:e0162483.
    PubMed     Abstract available

  70. STEVANOVIC J, de Jong LA, Kappelhoff BS, Dvortsin EP, et al
    Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands.
    PLoS One. 2016;11:e0163550.
    PubMed     Abstract available

  71. TANG Z, Wang X, Huang J, Zhou X, et al
    Gene Expression Profiling of Pulmonary Artery in a Rabbit Model of Pulmonary Thromboembolism.
    PLoS One. 2016;11:e0164530.
    PubMed     Abstract available

  72. MOUNTAIN D, Keijzers G, Chu K, Joseph A, et al
    RESPECT-ED: Rates of Pulmonary Emboli (PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or Small PE Rat
    PLoS One. 2016;11:e0166483.
    PubMed     Abstract available

  73. LEE DK, Kim HJ, Lee DH
    Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis.
    PLoS One. 2016;11:e0166844.
    PubMed     Abstract available

  74. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    PubMed     Abstract available

  75. HORVEI LD, Braekkan SK, Hansen JB
    Weight Change and Risk of Venous Thromboembolism: The Tromso Study.
    PLoS One. 2016;11:e0168878.
    PubMed     Abstract available

  76. HAI JJ, Chan PH, Chan YH, Fong CH, et al
    Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
    PLoS One. 2016;11:e0169095.
    PubMed     Abstract available

  77. SINDET-PEDERSEN C, Bruun Oestergaard L, Gundlund A, Fosbol EL, et al
    Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0169055.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.